1
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
Condition(s):SchizophreniaLast Updated:April 19, 2017Completed
Xanomeline as an Intervention: 10 Clinical Trials
Hide Studies Not Open or Pending
2
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
Condition(s):SchizophreniaLast Updated:March 20, 2023Recruiting
3
An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)
Condition(s):SchizophreniaLast Updated:March 20, 2023Active, not recruiting
4
An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia
Condition(s):SchizophreniaLast Updated:March 30, 2023Terminated
5
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Condition(s):SchizophreniaLast Updated:April 5, 2023Enrolling by invitation
6
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
Condition(s):Schizophrenia; Schizophrenia; PsychosisLast Updated:December 22, 2022Completed
7
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)
Condition(s):Schizophrenia; Schizophrenia; PsychosisLast Updated:November 8, 2022Completed
8
A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:October 26, 2020Completed
9
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Condition(s):SchizophreniaLast Updated:May 3, 2023Recruiting
10
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer’s Disease Dementia (ADEPT-1)
Condition(s):Psychosis Associated With Alzheimer’s Disease DementiaLast Updated:May 3, 2023Recruiting